A number of studies have provided strong evidence for the carcinogenic potential of IDH2 mutations, leading to the production of tumor metabolite 2-HG, which changes epigenetic regulation, cancer cell differentiation and cell metabolism. The gene discussed is IDH2; the disease is cancer.